Literature DB >> 16255004

Ventromedial medulla: pain modulation and beyond.

Peggy Mason1.   

Abstract

The midbrain periaqueductal gray (PAG) and ventromedial medulla (VMM) are generally viewed as the core of an endogenous descending modulatory system. However, available data demonstrate that PAG and VMM do not specifically target nociceptive transmission and that activation of either structure affects numerous homeostatic physiological processes. Pseudorabies virus (PRV) is a useful tracer that is retrogradely and transynaptically transported. PRV injections into homeostatic effector organs invariably label VMM neurons, both serotonergic and nonserotonergic. Studies in anesthetized rats have implicated two types of nonserotonergic VMM neurons in nociceptive modulation: ON cells are thought to facilitate nociception and OFF cells to inhibit nociception. Yet, in the unanesthetized animal, the discharge of VMM neurons changes in response to innocuous stimuli and during situations unrelated to nociception. In particular, VMM cells appear to modulate the timing of micturition, with ON cells promoting the initiation of voiding and OFF cells promoting urine storage. VMM cells also modulate sensory transmission. During both micturition and sleep, OFF cells discharge and sensory responsiveness is depressed. In sum, the VMM is hypothesized to modulate spinal sensory, autonomic, and motor circuits in order to maintain homeostasis. (c) 2005 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2005        PMID: 16255004     DOI: 10.1002/cne.20751

Source DB:  PubMed          Journal:  J Comp Neurol        ISSN: 0021-9967            Impact factor:   3.215


  30 in total

Review 1.  Diencephalic and brainstem mechanisms in migraine.

Authors:  Simon Akerman; Philip R Holland; Peter J Goadsby
Journal:  Nat Rev Neurosci       Date:  2011-09-20       Impact factor: 34.870

2.  Medullary raphe neurons facilitate brown adipose tissue activation.

Authors:  Malcolm W Nason; Peggy Mason
Journal:  J Neurosci       Date:  2006-01-25       Impact factor: 6.167

Review 3.  Neurobiological mechanisms for the regulation of mammalian sleep-wake behavior: reinterpretation of historical evidence and inclusion of contemporary cellular and molecular evidence.

Authors:  Subimal Datta; Robert Ross Maclean
Journal:  Neurosci Biobehav Rev       Date:  2007-03-12       Impact factor: 8.989

Review 4.  Organization of brain somatomotor-sympathetic circuits.

Authors:  Ilan A Kerman
Journal:  Exp Brain Res       Date:  2008-03-28       Impact factor: 1.972

5.  Microdissection of neural networks by conditional reporter expression from a Brainbow herpesvirus.

Authors:  J Patrick Card; Oren Kobiler; Joshua McCambridge; Sommer Ebdlahad; Zhiying Shan; Mohan K Raizada; Alan F Sved; Lynn W Enquist
Journal:  Proc Natl Acad Sci U S A       Date:  2011-02-03       Impact factor: 11.205

6.  Multimodal sensory responses of nucleus reticularis gigantocellularis and the responses' relation to cortical and motor activation.

Authors:  Eugene M Martin; Constantine Pavlides; Donald Pfaff
Journal:  J Neurophysiol       Date:  2010-02-24       Impact factor: 2.714

7.  Opioids disrupt pro-nociceptive modulation mediated by raphe magnus.

Authors:  Kevin M Hellman; Peggy Mason
Journal:  J Neurosci       Date:  2012-10-03       Impact factor: 6.167

8.  Musculoskeletal sensitization and sleep: chronic muscle pain fragments sleep of mice without altering its duration.

Authors:  Blair C Sutton; Mark R Opp
Journal:  Sleep       Date:  2014-03-01       Impact factor: 5.849

9.  Following one's heart: cardiac rhythms gate central initiation of sympathetic reflexes.

Authors:  Marcus A Gray; Karin Rylander; Neil A Harrison; B Gunnar Wallin; Hugo D Critchley
Journal:  J Neurosci       Date:  2009-02-11       Impact factor: 6.167

10.  Neonatal administration of thimerosal causes persistent changes in mu opioid receptors in the rat brain.

Authors:  Mieszko Olczak; Michalina Duszczyk; Pawel Mierzejewski; Teresa Bobrowicz; Maria Dorota Majewska
Journal:  Neurochem Res       Date:  2010-08-28       Impact factor: 3.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.